Evidence map›Paper›PMID 42643768›Full record

ReviewFrontiers in endocrinology2026

Artificial intelligence in thyroid ultrasound: clinical applications and perspectives.

Ye Guo, Tong Zhao, Lili Zhang, Yansong Liu, Kai Liu, Beibei Han, Yiming Zhao, Jiangbo Shao, Lirong Zhao

Abstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ye GuoCancer Center, The First Hospital of Jilin University, Changchun, Jilin, China.
Tong ZhaoImaging Center, The Third Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, Jilin, China.
Lili ZhangUltrasound Diagnostic Center, The First Hospital of Jilin University, Changchun, Jilin, China.
Yansong LiuUltrasound Diagnostic Center, The First Hospital of Jilin University, Changchun, Jilin, China.
Kai LiuDepartment of Hand and Foot Surgery, Orthopedics Center, The First Hospital of Jilin University, Changchun, Jilin, China.
Beibei HanDepartment of Hand and Foot Surgery, Orthopedics Center, The First Hospital of Jilin University, Changchun, Jilin, China.
Yiming ZhaoDepartment of Hand and Foot Surgery, Orthopedics Center, The First Hospital of Jilin University, Changchun, Jilin, China.
Jiangbo ShaoUltrasound Diagnostic Center, The First Hospital of Jilin University, Changchun, Jilin, China.
Lirong ZhaoUltrasound Diagnostic Center, The First Hospital of Jilin University, Changchun, Jilin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thyroid nodules are highly prevalent, with increasing detection rates driven by advanced imaging and expanded screening. Ultrasound serves as the first-line tool for screening, diagnosis and follow-up, owing to its non-invasiveness, real-time capability, cost-effectiveness and absence of ionizing radiation. However, conventional ultrasound diagnosis is highly operator-dependent, resulting in substantial inter-observer variability and diagnostic errors, particularly for subtle or indeterminate lesions. Artificial intelligence (AI), particularly deep learning and radiomics, has emerged as a promising approach to address these limitations by enabling automated feature extraction, quantitative analysis and standardized interpretation, which has the potential to improve diagnostic efficiency and risk stratification. This review summarizes AI applications in thyroid ultrasound, including image preprocessing, nodule segmentation, quantitative feature analysis, benign-malignant differentiation, TIRADS optimization and automated reporting. We highlight AI's potential in enhancing diagnostic consistency and accuracy, while critically assessing the methodological quality, bias risks and external validation of existing studies. Most AI tools are still in early translational phases, lacking large-scale validation in real clinical settings and standardized reporting protocols. We further discuss key challenges, including data bias, limited generalizability due to small or single-center datasets, poor interpretability and significant translational barriers. Future directions involving multi-modal fusion, explainable AI, real-time clinical systems and rigorous, multi-center standardized validation are proposed to facilitate clinical translation and improve patient care.

Indexed as

Artificial IntelligenceThyroid GlandThyroid NeoplasmsThyroid NoduleHumansImage Interpretation, Computer-AssistedRadiomicsUltrasonographyartificial intelligenceclinical translationrisk stratificationthyroid nodulethyroid ultrasound

Identifiers

PMID42643768
PMCPMC13504171

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.